BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Joint Venture - ECPv6.17.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Joint Venture
X-ORIGINAL-URL:https://jointventure-msk.com
X-WR-CALDESC:Events for Joint Venture
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20261013T090000
DTEND;TZID=Europe/London:20261013T170000
DTSTAMP:20260717T094424Z
CREATED:20260701T110813Z
LAST-MODIFIED:20260717T094424Z
UID:567-1791882000-1791910800@jointventure-msk.com
SUMMARY:Keep Britain Working: MSK Innovation in the Workplace
DESCRIPTION:How can we reduce the impact of poor musculoskeletal (MSK) health on people’s working lives?  \nHow can employers prevent the onset of MSK conditions and accommodate the needs of employees struggling with poor MSK health?  \nHow can we make the workplace environment more appropriate for an ageing workforce? \nWhat is the role for innovation in supporting employees and employers? \nDiscover the answers to these questions and more at the first MSK Innovation in the Workplace Conference. \nThe event will showcase breakthrough technologies\, practical deployment strategies\, and collaborative opportunities to help employers prevent work-related MSK conditions and enable people with poor MSK health to stay in the workplace or get back into work. \nFrom safety tech and assistive robotics\, to medical treatments and therapeutics\, the conference will highlight why innovation is a critical for getting our workforce moving. \nIt will include speakers from British Airways\, the British Standards Institute\, Transport for London\, Health & Safely Executive\, Make UK\, Society of Occupational Medicine\, Health Foundation\, Institute for Employment Research\, Unison\, Inspired Ergonomics\, Business for Health\, and the Centre for Musculoskeletal Health and Work. It will also feature experts in ergonomics and robotics and short presentations from start-ups developing innovative workplace solutions for MSK health. \nOrganised in partnership with \n \nTickets are available at a heavily discounted rate of £50 each. Places are strictly limited. \nBuy your ticket \nSponsorship packages are available\, with discounted rates for UK-based MSK start-ups. Contact m.thomas@oruk.org for further information\,
URL:https://jointventure-msk.com/event/keep-britain-working-msk-innovation-in-the-workplace/
LOCATION:Royal Society of Medicine\, 1 Wimpole Street\, London\, W1G 0AE\, United Kingdom
ATTACH;FMTTYPE=image/jpeg:https://jointventure-msk.com/wp-content/uploads/2026/07/AdobeStock_2060097046-scaled.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260630T140000
DTEND;TZID=Europe/London:20260630T153000
DTSTAMP:20260703T124612Z
CREATED:20260402T085746Z
LAST-MODIFIED:20260703T124612Z
UID:368-1782828000-1782833400@jointventure-msk.com
SUMMARY:Navigating the regulatory landscape - a notified body perspective.
DESCRIPTION:From a Notified Body’s viewpoint\, the fastest route to approval for orthopaedic start‑ups is disciplined preparation\, transparent evidence\, and early alignment with regulatory expectations. This webinar will be delivered by Kiwa (a world leader in testing\, inspection and certification)\, who will explain how certification bodies/notified bodies evaluate orthopaedic devices and how start‑ups can avoid the pitfalls that delay conformity assessment. \nThe webinar will feature a case study from Iestyn Foster\, Co-Founder & CEO of Amotio (an early-stage MSK business\, part-funded by ORUK) on how his company is navigating the regulatory landscape. \nThe agenda will cover: \n\nHow Notified Bodies View Orthopaedic Innovation\nClassification: The First Decision We Check\nWhat We Expect in Early Regulatory Strategy\nWhat a Notified Body Looks for in your QMS\nEvidence Requirements Through Our Lens\nWorking Effectively With Your Notified Body\nPost‑Market Surveillance: A Critical Part of Certification\nCertification as a Strategic Advantage\n\n \nBook your place
URL:https://jointventure-msk.com/event/navigating-the-regulatory-pathway/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://jointventure-msk.com/wp-content/uploads/2026/04/AdobeStock_1735447917-scaled.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260520T110000
DTEND;TZID=Europe/London:20260520T123000
DTSTAMP:20260518T182659Z
CREATED:20260318T083950Z
LAST-MODIFIED:20260518T182659Z
UID:91-1779274800-1779280200@jointventure-msk.com
SUMMARY:Accelerating MedTech Clinical Trials: New models\, real‑world delivery\, & why the UK can lead
DESCRIPTION:Undertaking clinical trials for MedTech devices in the UK has traditionally been expensive and slow. This webinar (hosted by Orthopaedic Research UK\, in association with clinical trials specialist VerIQ and the National Orthopaedic Alliance) will explore how the delivery of clinical studies in health tech and medical devices can be transformed and the UK become a leader in this area. \n\n\nIt will feature a distinguished group of speakers representing industry\, regulation\, clinical practice\, and clinical research delivery. \n\n\nIf you are involved with an MSK MedTech startup\, or a clinician or researcher thinking about starting commercial studies\, we highly recommend attending this free webinar. \nWebinar agenda: \n\nWelcome & brief introduction to Joint Venture\nMartin Thomas\, Head of Strategy\, ORUK\nIntroduction – Why the UK is well positioned to lead in MedTech clinical trials and the importance of new delivery models\nJoe Dupere\, CEO & co-founder VerIQ\nIndustry perspective on opportunities\, and what developers need from the UK ecosystem\nPaul Gibbons\, Chair of the Orthopaedics Committee\, ABHI and Managing Director\, Corin UK\nUK regulatory environment and the role of regulation in enabling innovation and efficient evidence generation\nDaniel Hill\, Deputy Head of Clinical Investigations\, Innovation and Compliance Group\, MHRA\nClinical site delivery\, NHS participation\, and the importance of coordinated research infrastructure (National Orthopaedic Alliance representative)\nProfessor Peter Kay\, Ex-National Clinical Director Musculoskeletal Services NHS England\nMultinational sponsor perspective on conducting MedTech clinical research in the UK\nJamie McDonald\, Associate Director\, Clinical Science & External Research\, DePuy Synthes Companies of Johnson & Johnson\nQ&A\, Hosted by Martin Thomas\, Head of Strategy\, ORUK & Professor Andy Metcalfe\, VerIQ co-founder and Professor in Trauma & Orthopaedics\, University of Warwick\n\n\n \n \nBook your place
URL:https://jointventure-msk.com/event/medtech-clinical-trials/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://jointventure-msk.com/wp-content/uploads/2026/03/AdobeStock_711851919-scaled.jpeg
END:VEVENT
END:VCALENDAR